| Trial ID: | L2864 |
| Source ID: | NCT02895672
|
| Associated Drug: |
Glp-1 Therapy
|
| Title: |
GLP-1/Basal Insulin Combination Therapy
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: GLP-1 therapy
|
| Outcome Measures: |
Primary: A1C, from baseline to 12 months after GLP-1 therapy is added to basal insulin therapy, 12 months |
|
| Sponsor/Collaborators: |
Sponsor: Albany College of Pharmacy and Health Sciences
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
150
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2016-08
|
| Completion Date: |
2016-12
|
| Results First Posted: |
|
| Last Update Posted: |
2017-02-02
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT02895672
|
